Compile Data Set for Download or QSAR
maximum 50k data
Found 309 Enz. Inhib. hit(s) with Target = 'Ubiquitin-like modifier-activating enzyme ATG7'
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM475984(US10865208, Compound I-42 | {(2R,3S,4R,5R)-5-[4-am...)
Affinity DataIC50:  14nMAssay Description:Inhibition of recombinant His-tagged human ATG7 incubated for 105 mins in presence of GST-tagged ATG3 and Flag-tagged Gabarap and measured after 2 hr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM475978(US10865208, Compound I-36 | {(2R,3S,4R,5R)-5-[4-am...)
Affinity DataIC50:  16nMAssay Description:Inhibition of recombinant His-tagged human ATG7 incubated for 105 mins in presence of GST-tagged ATG3 and Flag-tagged Gabarap and measured after 2 hr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476001(US10865208, Compound I-58 | {(2R,3S,4R,5R)-5-[4-am...)
Affinity DataIC50:  17nMAssay Description:Inhibition of recombinant His-tagged human ATG7 incubated for 105 mins in presence of GST-tagged ATG3 and Flag-tagged Gabarap and measured after 2 hr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476012(US10865208, Compound I-69 | [(2R,3S,4R,5R)-5-{4-am...)
Affinity DataIC50:  18nMAssay Description:Inhibition of recombinant His-tagged human ATG7 incubated for 105 mins in presence of GST-tagged ATG3 and Flag-tagged Gabarap and measured after 2 hr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476061(US10865208, Compound I-118 | {(2R,3R,4S,5R)-5-[4-a...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476022(US10865208, Compound I-79 | [(2R,3S,4R,5R)-5-(4-am...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476012(US10865208, Compound I-69 | [(2R,3S,4R,5R)-5-{4-am...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476008(US10865208, Compound I-65 | {(2R,3S,4R,5R)-5-[4-am...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476005(US10865208, Compound I-62 | {(2R,3S,4R,5R)-5-[4-am...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476001(US10865208, Compound I-58 | {(2R,3S,4R,5R)-5-[4-am...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476084(US10865208, Compound I-139 | {(2R,3R,4S,5R)-5-[4-a...)
Affinity DataIC50:  20nMAssay Description:Inhibition of recombinant His-tagged human ATG7 incubated for 105 mins in presence of GST-tagged ATG3 and Flag-tagged Gabarap and measured after 2 hr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476046(US10865208, Compound I-103 | {(2R,3R,4S,5R)-5-[4-a...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476056(US10865208, Compound I-113 | {(2R,3R,4S,5R)-5-[4-a...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476057(US10865208, Compound I-114 | [(2R,3R,4S,5R)-5-{4-a...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476032(US10865208, Compound I-89 | [(2R,3S,4R,5R)-5-{4-am...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476092(US10865208, Compound I-147 | {(2R,3R,4S,5R)-5-[4-a...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476093(US10865208, Compound I-148 | [(2R,3R,4S,5R)-5-{4-a...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476097(US10865208, Compound I-152 | [(2R,3R,4S,5R)-5-{4-a...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM475978(US10865208, Compound I-36 | {(2R,3S,4R,5R)-5-[4-am...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM475982(US10865208, Compound I-40 | [(2R,3S,4R,5R)-5-{4-am...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM475984(US10865208, Compound I-42 | {(2R,3S,4R,5R)-5-[4-am...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM475988(US10865208, Compound I-46 | [(2R,3S,4R,5R)-5-{4-am...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM475992(US10865208, Compound I-50 | [(2R,3S,4R,5R)-5-{4-am...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM475999(US10865208, Compound I-56 | {(2R,3S,4R,5R)-5-[4-am...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM475993(US10865208, Compound I-51 | {(2R,3S,4R,5R)-5-[4-am...)
Affinity DataIC50:  22nMAssay Description:Inhibition of recombinant His-tagged human ATG7 incubated for 105 mins in presence of GST-tagged ATG3 and Flag-tagged Gabarap and measured after 2 hr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM475994(US10865208, Compound I-52 | {(2R,3S,4R,5R)-5-[4-am...)
Affinity DataIC50:  23nMAssay Description:Inhibition of recombinant His-tagged human ATG7 incubated for 105 mins in presence of GST-tagged ATG3 and Flag-tagged Gabarap and measured after 2 hr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476126(US10865208, Compound I-181 | {(2R,3S,5R)-5-[4-amin...)
Affinity DataIC50:  27nMAssay Description:Inhibition of recombinant His-tagged human ATG7 incubated for 105 mins in presence of GST-tagged ATG3 and Flag-tagged Gabarap and measured after 2 hr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476025(US10865208, Compound I-82 | {(2R,3S,4R,5R)-5-[4-am...)
Affinity DataIC50:  29nMAssay Description:Inhibition of recombinant His-tagged human ATG7 incubated for 105 mins in presence of GST-tagged ATG3 and Flag-tagged Gabarap and measured after 2 hr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM475969(US10865208, Compound I-27 | {(2R,3S,4R,5R)-5-[4-am...)
Affinity DataIC50:  29nMAssay Description:Inhibition of recombinant His-tagged human ATG7 incubated for 105 mins in presence of GST-tagged ATG3 and Flag-tagged Gabarap and measured after 2 hr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476049(US10865208, Compound I-106 | [(2R,3R,4S,5R)-5-{4-a...)
Affinity DataIC50:  31nMAssay Description:Inhibition of recombinant His-tagged human ATG7 incubated for 105 mins in presence of GST-tagged ATG3 and Flag-tagged Gabarap and measured after 2 hr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476131(US10865208, Compound I-186 | {(2R,3S,5R)-5-[4-amin...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476139(US10865208, Compound I-194 | {(2R,3S,5R)-5-[4-amin...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476144(US10865208, Compound I-199 | [(2R,3S,5R)-5-{4-amin...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476145(US10865208, Compound I-200 | {(2R,3S,5R)-5-[4-amin...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476146(US10865208, Compound I-201 | {(2R,3S,5R)-5-[4-amin...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476086(US10865208, Compound I-141 | [(2R,3R,4S,5R)-5-{4-a...)
Affinity DataIC50:  35nMAssay Description:Inhibition of recombinant His-tagged human ATG7 incubated for 105 mins in presence of GST-tagged ATG3 and Flag-tagged Gabarap and measured after 2 hr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476049(US10865208, Compound I-106 | [(2R,3R,4S,5R)-5-{4-a...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476052(US10865208, Compound I-109 | [(2R,3R,4S,5R)-5-{4-a...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476054(US10865208, Compound I-111 | [(2R,3R,4S,5R)-5-{4-a...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476058(US10865208, Compound I-115 | {(2R,3R,4S,5R)-5-[4-a...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476059(US10865208, Compound I-116 | [(2R,3R,4S,5R)-5-{4-a...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476060(US10865208, Compound I-117 | [(2R,3R,4S,5R)-5-(4-a...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476065(US10865208, Compound I-122 | {(2R,3R,4S,5R)-5-[4-a...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476066(US10865208, Compound I-123 | [(2R,3R,4S,5R)-5-{4-a...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476069(US10865208, Compound I-126 | [(2R,3R,4S,5R)-5-{4-a...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476073(US10865208, Compound I-130 | [(2R,3R,4S,5R)-5-{4-a...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476074(US10865208, Compound I-131 | {(2R,3R,4S,5R)-5-[4-a...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476076(US10865208, Compound I-133 | [(2R,3R,4S,5R)-5-{4-a...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476078(US10865208, Compound I-135 | [(2R,3R,4S,5R)-5-{4-a...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Takeda Pharmaceuticals International

Curated by ChEMBL
LigandPNGBDBM476079(US10865208, Compound I-136 | US10865208, Compound ...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 309 total ) | Next | Last >>
Jump to: